State Street SPDR S&P Pharmaceuticals ETF

Frequently Asked Questions About XPH

What does XPH invest in?

SPDR Series Trust - SPDR S&P Pharmaceuticals ETF is an exchange traded fund launched by State Street Global Advisors, Inc. It is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. The fund invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Pharmaceuticals Select Industry Index, by using representative sampling technique. SPDR Series Trust - SPDR S&P Pharmaceuticals ETF was formed on June 16, 2006 and is domiciled in the United States.

What is the expense ratio of XPH?

State Street SPDR S&P Pharmaceuticals ETF (XPH) charges an expense ratio of 0.35%. This is the annual fee deducted from fund assets to cover management and operations.

How big is XPH?

State Street SPDR S&P Pharmaceuticals ETF (XPH) manages $440.4M in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure. Funds below ~$50M are at higher risk of liquidation.

Is XPH actively managed or an index fund?

XPH is a passive index fund. It tracks a published benchmark by holding the constituents in their published weights. Index funds typically charge low expense ratios (XPH's is 0.35%) because there's no security selection cost.

When was XPH launched?

State Street SPDR S&P Pharmaceuticals ETF (XPH) launched in June 2006 and is managed by SPDR.

How has XPH performed?

XPH's total return (price change plus reinvested distributions) is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.